Clinical Trial Update: Statin With Palliative Therapy for HCC [NA]

View source ↗

Summary

A clinical trial evaluating statin in combination with palliative therapy for hepatocellular carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Statin (unspecified)

Snippet

Sponsor: Taipei Medical University WanFang Hospital | Conditions: HCC | NA | Status: TERMINATED